SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $1.08B
Enterprise Value $850.83M
Beta -0.89
Average Volume 121.21K
Shares Outstanding (Diluted) 33.44M
Shares Change YoY N/A
Institutional Ownership 78.38%
Exchange NASDAQ
ISIN US85220G1094
Price Performance
Price Change 1M 24.6%
Price Change 3M 43.8%
Price Change 6M 35.1%
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 10.9%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR 31.6%
Valuation
PE Ratio -19.51
Forward PE N/A
PEG Ratio 0.14
Forward PEG -0.75
PS Ratio N/A
Forward PS N/A
PB Ratio 4.66
P/FCF Ratio -21.78
P/Adj. FCF Ratio -21.00
P/OCF Ratio -23.30
EV/Sales N/A
EV/EBIT -14.31
EV/EBITDA -14.56
EV/FCF -17.11
Earnings Yield -5.1%
FCF Yield -4.6%
Adj. FCF Yield -4.8%
Financial Health
Net Cash $234.19M
Total Debt $1.63M
Cash & Short-Term Investments $234.19M
Total Assets $243.43M
Current Ratio 25.06
Quick Ratio 25.06
Debt / Equity Ratio 0.01
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -28.53
Interest Coverage 0.00
Altman Z-Score 57.97
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -3.7%
Returns
Return on Assets -23.0%
Return on Equity -75.6%
Return on Invested Capital -26.5%
Return on Capital Employed -26.5%
Return on Tangible Assets -23.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 1
EPS Growth Next 3Y -28.3%
Revenue Growth Next 3Y N/A
Earnings Date Nov 5, 2026
EPS Estimate (next Q) -$0.66
EPS Growth Est (next Q) 47.4%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $38.00
Price Target Upside 17.3%
Cash Flow
Operating Cash Flow $-46.56M
Free Cash Flow $-49.74M
Adj. Free Cash Flow $-51.59M
FCF Per Share -$1.49
OCF Per Share -$1.39
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-875.73K
Operating Income $-62.11M
EBITDA $-58.43M
Net Income $-56.05M
EPS (Diluted) -$1.66
Revenue / Employee N/A
Profit / Employee $-737.54K
Employees 76
Add to Watchlist
Select watchlists to add or remove SGP